In Promising Early Trial, Oral Drug Cuts Heart-Disease Marker by Up to 65%
Best part: no intolerable side effects.
from ScienceAlert https://ift.tt/pzc8Q1f
PHARMACY PRACTICE ACTIVITIES FORUM (PPAF) website for all the pharmacist friends who wise to publish their creative work and health-related information. This website is built for educational purposes only.PPAF will regularly update all health-related activities for the pharmacist community.
Best part: no intolerable side effects.
Comments
Post a Comment